Schedule 13D ownership disclosure
Skye Bioscience, Inc.
Security class unavailable · CUSIP: 83086J101
Event date: 2023-08-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,110,709,567
- Percent of class
- 31.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-096002
- Form type
- SC 13D
- Filer
- 5AM Partners VII, LLC
- CIK
- CIK 1873545
- Filed
- Aug 28, 2023
- Reporting period
- Aug 18, 2023
- Description
- Schedule 13D beneficial ownership